BEAM
KLRS

Baker Ellis Asset Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Baker Ellis Asset Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-435
Closed -$6.8K – 224
2023
Q4 		$6.8K Buy
+435
New +$6.8K ﹤0.01% 216